Lombard Odier Asset Management (Switzerland)’s Abiomed Inc ABMD Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-22,500	Closed	-$6.43M	–	400
2019 Q1	$6.43M	Buy	+22,500	New	+$7.48M	0.65%	42
2017 Q3	–	Sell	-5,000	Closed	-$717K	–	398
2017 Q2	$717K	Sell	5,000 -35,000	-88%	-$4.7M	0.08%	214
2017 Q1	$5.01M	Hold	40,000	–	–	0.56%	46
2016 Q4	$4.51M	Buy	40,000 +24,000	+150%	+$2.78M	1.14%	31
2016 Q3	$2.06M	Buy	+16,000	New	+$1.92M	0.49%	38

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s ABMD Position: Q2 2019 in Review

Lombard Odier Asset Management (Switzerland) sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 22,500 shares — an estimated $6.43M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in ABMD in Q3 2016 and held it in 5 quarters. The position peaked at $6.43M in Q1 2019. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

Lombard Odier Asset Management (Switzerland) reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 22,500 Abiomed Inc shares in Q2 2019, an estimated $6.43M.
Lombard Odier Asset Management (Switzerland) first reported a position in Abiomed Inc in Q3 2016 and held it in 5 quarters.
Lombard Odier Asset Management (Switzerland)'s Abiomed Inc position peaked at $6.43M in Q1 2019.
484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2019, filed 14 Aug 2019.